Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer

Journal of Physiology and Pharmacology

Volumn 60, Issue SUPPL. 1, 2009, Pages 65-71

  Niedzielska, Iwona ^a,d   Niedzielski, Z ^b   Tkacz, M ^c   Orawczyk, T ^a   Ziaja, K ^a   Starzewski, J ^a   Mazurek, U ^a   Markowski, J ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b State Hospital   (Poland)

^c UNIVERSITY OF SILESIA   (Poland)

^d NONE   (Poland)

Author keywords

Adenocarcinoma; Microarray analysis; Polyp colon; Proinflammatory cytokines; Toll like receptors

Indexed keywords

MESSENGER RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ADULT; AGED; CANCER STAGING; CLINICAL ARTICLE; COLON MUCOSA; COLON POLYP; COLON POLYPOSIS; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; COLON; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TOLL-LIKE RECEPTORS;

EID: 67749119808     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Jacobson-Brown P, Neuman MG. Colon polyps and cytokines: emerging immunological mechanisms. Rom J Gastroenterol 2003; 12: 207-214. (Pubitemid 37152606)
2. Jacobson-Brown P, Neuman MG. Colorectal polyposis and immune-based therapies. Can J Gastroenterol 2004; 18: 239-249.
3. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-305. (Pubitemid 34303674)
4. Nishiya T, DeFranco AL. Ligand-regulated chimeric approach reveals distinctive subcellular localization and signaling properties of the TLRs. J Biol Chem 2004; 279: 19008-19017. (Pubitemid 38623331)
5. Giles PJ, Kipling D. Normality of oligonucleotide microarray data and implications for parametric statistical analyses. Bioinformatics 2003; 19: 2254-2262. (Pubitemid 37492832)
6. Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001; 120: 1077-1083. (Pubitemid 32246661)
7. Gewirtz A, Navas T, Lyons S, Godowski P, Madara J. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167: 1882-1885. (Pubitemid 32747491)
8. Huang B, Zhao J, Li H et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005; 65: 5009-5014. (Pubitemid 40827306)
9. Fukata M, Chen A, Vamadevan AS et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007; 133: 1869-1881. (Pubitemid 350186162)
10. Wang L, Liu Q, Sun Q, Zhang C, Chen T, Cao X. TLR4 signaling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20. Biochem Biophys Res Commun 2008; 366: 852-856.
11. Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Michel-Schmidt R, Kirkpatrick CJ. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int J Mol Med 2007; 20: 21-29.
12. 2 production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation. Mol Immunol 2008; 45: 2929-2936.
13. Tokunaga T, Yano O, Kuramoto E et al. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 1992; 36: 55-66.
14. Kandimalla ER, Bhagat L, Li Y et al. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists. Proc Natl Acad Sci USA 2005; 102: 6925-6930. (Pubitemid 40675418)
15. Rayburn ER, Wang W, Zhang R, Wang H. Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53. Int J Oncol 2007; 30: 1511-1519.
16. Rhee SH, Im E, Pothoulakis C. Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer. Gastroenterology 2008; 135: 518-528.
17. Toiyama Y, Araki T, Yoshiyama S, Hiro J, Miki C, Kusunoki M. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today 2006; 36: 287-290. (Pubitemid 43288728)
18. NIST/SEMATECH e-Handbook of Statistical Methods. http://www.itl.nist.gov/ div898/handbook/eda/section1/eda11.htm